Inhibition of placental growth factor was effective in prolonging survival of imatinib-sensitive and -resistant CML mice [83], thus identifying another target that is crucial in the survival and growth of CML. The gene discussed is PGF; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.